Related Experiment Videos
Cellular attachment to thrombospondin. Cooperative interactions between receptor systems
A S Asch1, J Tepler, S Silbiger
1Department of Medicine, Cornell University Medical College, New York, New York 10021.
The Journal of Biological Chemistry
|January 25, 1991
Summary
Tumor cells use multiple receptors, including glycoprotein IV (GPIV) and heparin-binding systems, to attach to thrombospondin (TSP). This interaction is crucial for cancer invasion and spread, with different cell types utilizing distinct receptor combinations.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Tumor cell interaction with extracellular matrix thrombospondin (TSP) is vital for cancer invasion and metastasis.
- Understanding the specific receptor systems involved is key to targeting these processes.
Purpose of the Study:
- To investigate the receptor systems mediating tumor cell attachment to insoluble TSP.
- To elucidate the roles of glycoprotein IV (GPIV) and heparin-binding interactions in tumor cell adhesion.
Main Methods:
- Studied attachment of HT1080 fibrosarcoma and C32/G361 melanoma cells to TSP-coated discs.
- Utilized heparin, Arg-Gly-Asp-Ser peptide, and antibodies against GPIV (CD36).
- Examined binding to intact TSP and TSP fragments lacking specific domains.
Main Results:
- HT1080 and C32 cells required both heparin and anti-GPIV antibodies for significant TSP attachment inhibition.
- Heparin alone promoted cell spreading, while Arg-Gly-Asp-Ser had no inhibitory effect.
- G361 cells, lacking GPIV, showed attachment inhibition with heparin and Arg-Gly-Asp-Ser, suggesting integrin involvement.
- Binding to TSP fragments indicated GPIV and heparin-modulated systems function independently and cooperatively.
Conclusions:
- Tumor cells employ cooperative and distinct receptor systems for TSP adhesion.
- HT1080 and C32 cells utilize GPIV alongside heparin-modulated systems.
- G361 cells use integrins and heparin-modulated systems, highlighting cell-type specific mechanisms in cancer metastasis.